KNR Constructions Robust Performance on Execution Ramp-up

Similar documents
BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

Nestlé India Outlook Hazy; Valuations Prohibitive

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

KEC International. Recovering from a weak phase. Institutional Equity Research. Order inflow traction remains intact

Simplex Infrastructures

Ahluwalia Contracts (India)

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

HCC BUY. Infrastructure April 10, QIP step in the right direction EVENT UPDATE. India Research. Bloomberg: HCC IN Reuters: HCNS.

Strides Arcolab. Inline 4Q, recent acquisitions to deepen asset growth. Institutional Equity Research. Strides Arcolab. Pharmaceuticals India

Colgate-Palmolive (India)

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Amber Enterprises India Ltd

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Hindustan Media Ventures

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Visaka Industries Ltd

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Sonata Software BUY. Laying the Platform for Growth. Institutional Equity Research. December 01, Target Price Rs185.

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

Cummins India Ltd Bloomberg Code: KKC IN

Institutional Equities

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Key estimate revision. Financial summary. Year FY14 391,088 45,198 34, FY15E 354,262 35,426 23,

ITC ACCUMULATE. Performance Highlights CMP. `257 Target Price `284. 3QFY2017 Result Update FMCG. Investment Period 12 Months

Hindustan Unilever (RHS)

Gillette India. Institutional Equities. 1QFY18 Result Update

Kalpataru Power. Rating: Target price: EPS: Rating CMP. Target BUY. Rs Rs.256

Larsen & Toubro Ltd.

Adani Ports & SEZ Rating: Target price: EPS:

Indian Oil Corporation

Fineotex Chemical Ltd

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Inox Wind BUY. Performance Highlights. CMP Target Price `390 `505. 2QFY2016 Result Update Capital Goods. 3 year price chart

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

EBITDA 5,076 3, , EBITDA

Robust results, TLT margins improved profitability.

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Transport Corporation of India Ltd.

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Bharat Forge. Result Update. Q4FY13 Result Highlights. Valuation. No Respite in Sight May 29, Institutional Research 1

Greenply Industries BUY. The plywood maker for growing India. Target Price. Initiating Coverage Plywood. 3-year price chart.

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Bank of Baroda (BOB) Banking. BUY Rating as per Large Cap 12 month investment period RETAIL EQUITY RESEARCH

KEC International Ltd.

Dalmia Bharat Enterprises

Mahindra & Mahindra Ltd.

RBL Bank Ltd. Banking. ACCUMULATE Rating as per Mid Cap 12 months investment period RETAIL EQUITY RESEARCH

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

ICICI Bank Banking BUY RETAIL EQUITY RESEARCH

Mahindra & Mahindra Ltd.

Bajaj Finance Limited (BFL) NBFC. BUY Rating as per Large Cap 12 months investment period RETAIL EQUITY RESEARCH

Transport Corporation of India Ltd.

Havells India. Q1FY18 Result Update Strong Sales growth; Margins decline. Sector: Consumer Durable CMP: ` 467. Recommendation: BUY

Parag Milk Foods BUY. Performance Update CMP. `324 Target Price `410. 1QFY2019 Result Update Dairy Products. Investment Period 12 Months

Skipper Ltd. May 17, Towering high. CMP INR 205 Target INR 238 Result Update - BUY. Company Background. Investment Rationale

Techno Electric & Engineering Limited

Rallis India NEUTRAL. Performance Highlights CMP. `237 Target Price - 1QFY2018 Result Update Agrichemical. Investment Period - 3-year price chart

Transcription:

Market Cap. (Rs bn) 18 Free Float (%) 39 Shares O/S (mn) 28 KNR Constructions Robust Performance on Execution Ramp-up KNR Constructions (KNRC) has reported a better-than-expected performance in 1QFY17, as healthy inflow seen over last 12-months and execution ramp-up from new projects led to robust ~74% yoy growth in revenue to Rs3.06bn way ahead our estimate. EBITDA stood strongly at Rs442mn (+58% yoy) and EBITDA margin continued to remain healthy at ~14.5% (flat on adjusted last year s margins). Reported PAT surged by 101% yoy to Rs302mn vs. our estimate of Rs279mn mainly owing to better top-line growth and lower-than-anticipated tax rate. We continue to maintain our positive stance on KNRC mainly on account of healthy order book (4.9x TTM revenue), strong balance sheet (0.1x net D/E) and sound execution credentials well-proved by track record of early completions, which we believe would boost to growth, going forward. Hence, we reiterate our recommendation on the stock with a revised SOTP-based Target Price of Rs770. Strong show led by healthy inflows Revenue booking remained robust as revenue grew 74% yoy & 3% qoq to Rs3.03bn in 1QFY17 primarily owing to execution ramp-up from fresh projects (secured Rs29bn orders in FY16 & Rs17.5bn till date in FY17E). EBITDA margin continued to remain healthy and stood at strong ~14.5%. PAT came in at Rs302mn (+101% yoy) ahead of the expectations. Robust Order Backlog oers Growth Visibility KNRC s current order backlog at Rs49.2bn (Rs42.6bn as on June 30, 2016), which is ~4.9x TTM revenue, lends sound visibility of future growth. It bagged orders worth Rs29bn in FY16 and has further secured orders over Rs17.5bn in FY17E till date. Further, 93% of its total order book is from the government while 6% orders are from international clients. Share price (%) 1 mth 3 mth 12 mth Absolute performance 12.6 22.5 21.3 Relative to Nifty 8.4 12.2 20.0 Shareholding Pattern (%) Mar 16 Jun 16 Promoter 60.8 60.8 Public 39.3 39.3 1 Year Stock Price Performance 700 650 600 550 500 450 400 350 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 Aug-16 Note: *CMP as on August 16, 2016 Outlook and Valuation In our view, strong show in order-inflow in FY16 and 1QFY17 ytd coupled with execution ramp-up from new projects will aid KNRC to witness a healthy growth, going ahead. Healthy order book, sound execution credentials and light balance-sheet are expected to fuel growth of 43% & 31% CAGR in Revenue & APAT over FY16- FY18E. Hence, we maintain our recommendation on the stock with a revised SOTP-based Target Price of Rs770, valuing KNRC s standalone business at Rs696/ share based on 11x FY18E earnings and Kerala & Bihar BOT at Rs74 (at 1x P/BV). Key Financials (Rs mn) FY15 FY16P FY17E FY18E Sales 8,761 8,851 13,043 18,167 EBITDA 1,261 1,380 1,865 2,634 Net Profit 785 1,036 1,392 1,774 EPS (Rs) 27.9 36.8 49.5 63.1 DPS (Rs) 1.2 1.2 1.2 1.2 P/E (x) 23.0 17.4 13.0 10.2 P/B (x) 3.2 2.5 2.1 1.7 EV/EBITDA 14.9 13.8 10.1 7.0 RoE (%) 14.5 16.0 17.5 18.7 Divi. Yield (%) 0.2 0.2 0.2 0.2 Research Analyst: Binod Modi Contact: (22) 33201097 Email: binod.modi@relianceada.com 1

Risks to the view Delay in execution Geographical diversification may put pressure on margins Conference Call Key Highlights Roads Projects: Road projects over 10,000kms were awarded and over 6,000kms were constructed in FY16. Further, the Government targets to award 25,000kms in FY17E (2.5x FY16) and intends to construct 15,000kms (including 8,000kms NHAI roads) in FY17E. Adoption of land acquisition act by several states is helping the overall roads and highway sector. Order-inflow Guidance: KNRC added orders worth >Rs17.5bn till date in FY17E in roads and irrigation segment. It expects further to add orders to the tune of ~Rs10-15bn during FY17E. Thus it is likely to exceed its earlier inflow guidance of Rs20-25bn for FY17E. Though KNRC s current bidding pipeline is less than Rs5.0bn, it expects several tenders to come-up post monsoon. KNRC envisages many roads projects to come up especially from Uttar Pradesh & Bihar. Further, lots of irrigation projects are also expected to come up from Talangana. Revenue & Margin Guidance: It has guided for revenue of Rs12.0bn in FY17E and Rs17.0bn in FY18E with an average EBITDA margin of 13.5-14.5%. Tax rate for FY17E is guided at 8-10% and 12% for FY18E based on current order book. KNRC intends to double its revenue by FY20E. Capex: Given the significant spike in order inflow, it has increased its capex guidance to Rs800-850mn from Rs500-600mn for FY17E, while the capex for FY18E is also expected to be in the same range. BOT Project (Walayar Toll-ways): KNRC s toll collection stood at Rs95.8mn in 1QFY17, which is way below considering the revenue expectations of Rs500mn for FY17E. Management cited that non-completion of a stretch at one-end (being executed by other contractor) is hurting traic as of now. KNRC is expected to infuse additional equity of ~Rs800mn for this project. Muzaarpur-Barauni BOT Project: Provisional Completion Certificate for 75% of project length has been issued on June 03, 2016. Toll collection from the project recorded at Rs12.2mn in 1QFY17. Working Capital Cycle: Working capital cycle stands at 45 days. Debtors & Inventory levels stand at Rs1.38bn & Rs400mn, respectively while payable stands at Rs1.4bn. Gross standalone and consolidated debt stands at Rs1.0bn & Rs7.5bn, respectively. Loans and advances to subsidiary reached at Rs2.5bn. 2

Market Cap. (Rs bn) 18 Free Float (%) 39 Shares O/S (mn) 28 Exhibit 1: Result Summary (Rs mn) 1QFY17 1QFY16 % yoy chg 4QFY16 % qoq. chg FY16 FY15 % yoy chg Net Sales 3,036 1,746 73.9 2,943 3.2 8,851 8,760 1.0 Expenses Cost of materials consumed 793 839 (5.5) 707 12.2 2,792 3,370 (17.2) Changes in WIP 0 0 % sales 26.1 48.1 24.0 31.5 38.5 Employee Costs 129 98 30.8 116 11.3 435 381 14.3 % sales 4.2 5.6 3.9 4.9 4.3 Spreading & Assortment Exps. 423 186 127.7 530 (20.1) 1,587 989 60.5 % sales 13.9 10.6 18.0 17.9 11.3 Sub-contract exps. 956 157 508.9 793 20.5 1,684 1,606 4.8 % sales 31.5 9.0 26.9 19.0 18.3 Other Exps. 294 186 58.2 362 (18.8) 973 1,154 (15.6) % sales 9.7 10.6 12.3 11.0 13.2 Total Exps. 2,595 1,466 76.9 2,507 3.5 7,471 7,500 (0.4) EBITDA 442 280 57.8 436 1.2 1,380 1,260 9.5 EBITDA margins (%) 14.5 16.0 (148.6) 14.8 (1.9) 15.6 14.4 120.0 Depreciation 132 105 24.9 110 19.9 431 541 (20.2) Finance Costs 43 25 68.8 40 5.9 126 122 3.1 Other Income 54 22 148.7 169 (68.1) 479 126 281.5 PBT 321 171 87.9 455 (29.4) 1,301 723 80.0 Tax Exps. 19 21 (8.8) (125) (310) (7) % PBT 5.9 12.1 PAT 302 150 101.3 580 (47.9) 1,611 730 120.7 APAT 302 150 101.3 385 (21.4) 1,036 730 41.9 Net Margins (%) 9.0 8.6 19.7 18.2 8.3 Exhibit 2: Revised v/s Old estimates FY17E FY18E Old Revised % change Old Revised % change Sales 12,435 13,043 4.9 17,403 18,167 4.4 EBITDA 1,840 1,865 1.4 2,610 2,634 0.9 EBITDA margins (%) 14.8 14.3 15.0 14.5 PAT 1,371 1,392 1.5 1,732 1,774 2.4 EPS (Rs) 48.7 49.5 1.6 61.6 63.1 2.4 Source: RSec Research 3

Exhibit 3: A snapshot of key orders Key Projects Rs bn Madurai Ramanathpuram Project 7.45 Thiruvananthapuram Bypass from Kazhakkoottam to Mukkola Junction 5.71 Upgrading Arcot Villupuram Road 3.06 Rehabilitation and upgradation of Dindigul-Bangalore Road (Pollachi to Coimbatore Section) 4.15 Flyover in Salem- TN 2.87 Top 5 Road Projects 23.24 Other Road Projects 12.04 Irrigation Projects 7.3 Total Order Book 42.58 Exhibit 4: Segmental Order Break-up (%) Exhibit 5: Geographical Break-up (%) 17 1 6 6 83 87 Road (Third Parties) Irrigation South East Central International 4

Profit & Loss Statement Y/E March (Rs mn) FY15 FY16 FY17E FY18E Income 8,761 8,851 13,043 18,167 % yoy growth 4.3 1.0 47.4 39.3 Operting Expenses 7,500 7,471 11,178 15,533 EBITDA 1,261 1,380 1,865 2,634 EBITDA Margin (%) 14.4 15.6 14.3 14.5 Depreciation & Amortization 541 431 410 389 Interest 122 126 153 147 Other Income 125 479 336 268 PBT 723 1,301 1,637 2,366 Tax (7) (310) 246 591 % Tax (1.0) (23.8) 15.0 25.0 Net Profit- Reported 730 1,611 1,392 1,774 YoY Growth (%) 19.7 120.7 (13.6) 27.5 Net Profit- Adjusted 785 1,036 1,392 1,774 Net Profit Margin (%) 9.0 11.7 10.7 9.8 Balance Sheet Y/E March (Rs mn) FY15 FY16P FY17E FY18E Sources of Funds Share Capital 281 281 281 281 Reserves & Surplus 5,412 6,991 8,350 10,091 Total Shareholder's funds 5,693 7,272 8,631 10,372 Loans 964 1,171 1,125 1,276 Deferred Tax Liability (net) (239) (276) (276) (276) Total Liabilities 6,418 8,167 9,480 11,372 Application of Funds Gross Fixed Assets 5,509 6,056 6,856 7,656 Less: Acc. Depreciation 3,156 3,587 3,997 4,386 Net Fixed Assets 2,353 2,468 2,858 3,269 Investments 315 434 474 514 Inventories 420 353 528 736 Sundry Debtors 1,765 1,294 1,799 2,565 Other Current Assets 1,638 1,617 2,348 3,452 Cash & Bank Balances 157 163 289 761 Loans & Advances 3,542 6,178 7,043 8,175 Toal Current Assets 7,522 9,604 12,008 15,690 Current Liabilities 3,463 3,807 5,404 7,465 Provisions 309 532 456 636 Total Current Liabilities 3,772 4,340 5,860 8,101 Net Current Assets 3,749 5,265 6,148 7,589 Misc. Expenditure 0 0 0 0 Total Assets 6,418 8,167 9,480 11,372 5

Cash Flow Statement Y/E March (Rs mn) FY15 FY16E FY17E FY18E PBT 723 1,301 1,637 2,366 Depreciation 541 431 410 389 Tax Paid (114) (209) (246) (591) Net Change in Working Capital (358) 1,126 109 163 Others 122 126 153 147 Net Cash from Oper. Activities 914 2,777 2,064 2,475 Capex (390) (547) (800) (800) Sale / (Purchase) of Investments (379) (2,272) (905) (1,172) Net Cash used in Invest Activities (769) (2,819) (1,705) (1,972) Finance cost (155) (159) (186) (180) Proceeds from Equity - - - - Proceeds from Debt 56 208 (46) 150 Others - - - - Net Cash used in Fin. Activities (99) 49 (232) (30) Net Increase/ (Decrease) in Cash 45 6 126 472 Cash at Beginning of the Year 112 157 163 289 Cash at End of the Year 157 163 289 762 Key Ratios Y/E March FY15 FY16E FY17E FY18E Valuation Ratio (x) P/E 23.0 17.4 13.0 10.2 P/CEPS 14.2 8.8 10.0 8.3 P/BV 3.2 2.5 2.1 1.7 EV/EBITDA 14.9 13.8 10.1 7.0 EV/Sales 2.1 2.2 1.4 1.0 Dividend Payout (%) 6.9 3.8 3.0 2.1 Dividend Yield (%) 0.2 0.2 0.2 0.2 Per Share Data (Rs) EPS (Basic) 27.9 36.8 49.5 63.1 EPS (Diluted) 27.9 36.8 49.5 63.1 CEPS 45.2 72.6 64.1 76.9 DPS 1.2 1.2 1.2 1.2 Book Value 202 259 307 369 Returns (%) RoCE 13.7 19.6 20.3 24.1 RoE 14.5 16.0 17.5 18.7 Turnover ratios (x) Asset Turnover 1.6 1.5 1.9 2.4 Inventory (days) 16 16 12 13 Receivables (days) 61 63 60 60 Payables (days) 31 38 36 35 WCC (days) 46 41 36 38 Solvency ratios (x) D/E (x) 0.14 0.1 0.1 0.0 Current Ratio (x) 2.0 2.2 2.0 1.9 6

Rating Guides Rating Expected absolute returns (%) over 12 months >10% HOLD -5% to 10% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or oering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, ailiates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, ailiates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely aected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces aecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be aected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may aect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an oicer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U65990MH2005PLC154052. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 011234839, Depository Participants: CDSL IN-DP-257-2016 IN-DP-NSDL-363-2013, Research Analyst: INH000002384); AMFI ARN No.29889. 7